KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Equity Average: 2009-2025

Historic Equity Average for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to $514.1 million.

  • Dynavax Technologies' Equity Average fell 22.35% to $514.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.1 million, marking a year-over-year decrease of 22.35%. This contributed to the annual value of $609.4 million for FY2024, which is 1.31% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Equity Average is $514.1 million, which was up 0.31% from $512.6 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Equity Average ranged from a high of $662.1 million in Q3 2024 and a low of $75.5 million during Q3 2021.
  • In the last 3 years, Dynavax Technologies' Equity Average had a median value of $591.1 million in 2023 and averaged $590.0 million.
  • As far as peak fluctuations go, Dynavax Technologies' Equity Average skyrocketed by 687.78% in 2021, and later dropped by 22.35% in 2025.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Equity Average stood at $145.0 million in 2021, then spiked by 273.03% to $540.8 million in 2022, then grew by 13.44% to $613.5 million in 2023, then rose by 4.18% to $639.1 million in 2024, then declined by 22.35% to $514.1 million in 2025.
  • Its Equity Average was $514.1 million in Q3 2025, compared to $512.6 million in Q2 2025 and $563.9 million in Q1 2025.